Testing effectiveness (Phase 2)Ended earlyNCT03490942
What this trial is testing
Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses
Who this might be right for
Hypoglycemia UnawarenessDiabetes Mellitus, Type 1
Xeris Pharmaceuticals 49